The QualityStocks Daily Tuesday, October 26th, 2021

Today's Top 3 Investment Newsletters

MarketClub Analysis(IINN) $9.59 +308.09%

Tiny Gems(MSGP) $2.31 +225.35%

QualityStocks(BIMI) $2.21 +225.00%

The QualityStocks Daily Stock List

BIMI International Medical Inc. (BIMI)

StockMarketWatch, MarketClub Analysis, TradersPro, StreetInsider, Real Pennies, QualityStocks, TradersPro Morning, TopPennyStockMovers, TheMicrocapNews, PennyStockRumors.net, OilAndEnergyInvestor and InvestorsUnderground reported earlier on BIMI International Medical Inc. (BIMI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

BIMI International Medical Inc. (NASDAQ: BIMI) (FRA: 63NN) is focused on the wholesale and retail distribution of medical devices and other healthcare and pharmaceutical products in China.

The firm has its headquarters in Dalian, in the People’s Republic of China and was incorporated in 2000, on October 31. Prior to its name change in December 2019, the firm was known as NF Energy Saving Corporation. It operates in the consumer staples sectors, under the retail-consumer staples sub-industry and serves consumers in China.

The company’s objective is to establish a chain of hospitals that specialize in gynecology and obstetrics. It’s currently transforming to a locally-focused and community-based health service and medical provider, from a provider of energy management re-engineering project operations, technical services and energy conservation solutions. It plans to offer seamless, simple, accessible and affordable care to consumers when and where they need it.

The enterprise provides health foods, nutritional supplements, over-the-counter and prescription drugs and sundry products as well as miscellaneous items. It markets family care and personal care products and traditional Chinese medicines via the Lijiantang Pharmacy brand. This is in addition to promoting the layout in the fields of medical services and offering development and IT research services. The enterprise sells medications and other healthcare products to consumers via its directly owned stores, under the Boqi Pharmacy brand name.

The firm recently announced that its Chongqing Shude Pharmaceutical Co. Ltd, its subsidiary, was awarded a contract worth about RMB 20 million ($3.126 million) by Huilian Medicine. This move will advance the firm’s expansion strategy, which centers on deeper penetration of the healthcare market in Southwest China, which is bound to bring in more investors.

BIMI International Medical Inc. (BIMI), closed Tuesday’s trading session at $2.21, up 225%, on 215,794,419 volume. The average volume for the last 3 months is 215.794M and the stock's 52-week low/high is $0.53/$2.81.

Molecular Data (MKD)

StreetInsider and QualityStocks reported earlier on Molecular Data (MKD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Molecular Data Inc. (NASDAQ: MKD) operates a technology-driven platform in the chemical industry of China, which connects participants along the chemical value chain using integrated solutions. The firm uses a data-driven and SaaS-powered service platform to operate chemical e-commerce businesses in China, through its subsidiaries.

Molecular Data Inc. was founded in 2013 by Li Li and Dong Liang Chang and has its headquarters in Shanghai, the People’s Republic of China. The firm provides SaaS (software-as-a-service) suites that are meant to solve any issues participants in the chemical industry might come across.

Additionally, the firm generates all its revenues from China through chemical trading and sells chemical products to its consumers though either sales representatives or online platforms. Molecular Data Inc. also provides e-commerce solutions through its online platform that has been built on extensive artificial intelligence and knowledge engine capabilities. The platform consists of Chemical Community App, Moku Data Weixin account, molbase.cn and molbase.com.

The firm delivers logistics and warehousing solutions, financial solutions, and e-commerce solutions in China.

As of December 2020, the tech platform had appointed Steven Foo as the firm’s new Chief Financial Officer. With his extensive financial, asset management and analyst background, many believe Mr. Foo will usher Molecular Data Inc. into its next growth phase.

Molecular Data (MKD), closed Tuesday’s trading session at $0.415, up 20.8855%, on 41,952,675 volume. The average volume for the last 3 months is 41.953M and the stock's 52-week low/high is $0.2714/$2.23.

Meten EdtechX Education Group (METX)

QualityStocks, MarketClub Analysis, MarketBeat and INO Market Report reported earlier on Meten EdtechX Education Group (METX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Meten EdtechX Education Group Ltd (NASDAQ: METX) is an English Language Training service provider which offers English language and future skills training for Chinese professionals and students. The firm offers its services through a nationwide network of learning centers as well as a digital platform.

Meten EdtechX Education Group Ltd was established in 2006 and has its headquarters in Shenzhen, China. The firm operates through 4 segments, i.e. Junior English Training, Overseas Training Services, Online English Training, and General Adult English Training.

Meten EdtechX Education Group’s objective is to improve the overall English language competitiveness and competence of the Chinese population, in an attempt to keep up with the globalization’s rapid development.

The firm offers its services under the following brand names: Likeshuo, which offers online English language training services, ABC which is mostly comprised of junior English Language Training services, and Meten which offers junior and adult ELT services. Meten EdtechX uses A1-driven centralized management and teaching systems across its business, which analyze and record learning processes in the present time thus providing superior teaching quality and student satisfaction.

Meten EdtechX Group Ltd has 149 learning centers distributed in 36 cities covering 18 provinces in China. With a total addressable market of more than 600 cities in China and forecasts showing that the urban population in China will reach one billion in less than a decade, Meten EdtechX Group Ltd is in for significant growth in the years to come, especially if one factors in the increasing demand for bilingual talents and the growing numbers of students who are studying abroad.

Meten EdtechX Education Group (METX), closed Tuesday’s trading session at $0.55, up 44.357%, on 995,419,406 volume. The average volume for the last 3 months is 995.419M and the stock's 52-week low/high is $0.28/$4.2699.

Iterum Therapeutics (ITRM)

MarketBeat, StreetInsider, MarketClub Analysis, TradersPro, StockMarketWatch and QualityStocks reported earlier on Iterum Therapeutics (ITRM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Iterum Therapeutics Plc. (NASDAQ: ITRM) is a pharmaceutical firm which is involved in the development and commercialization of anti-infectives that treat pathogens which are resistant to drugs.

The firm was founded on June 24, 2015 by Corey N. Fishman and makes up part of the pharmaceutical manufacturing industry. Iterum Therapeutics Plc. has its headquarters in Dublin, Ireland.

Iterum Therapeutics serves patients and physicians across the globe and its products are designed to combat pathogens which are drug resistant. This is geared at improving the lives of individuals who have been affected by severe and life-threatening ailments across the globe.

The firm is currently developing an anti-infective compound with IV and oral formulations known as sulopenem. The product candidate has shown that it has the potential to fight against anaerobic, gram-positive and gram-negative bacteria that is resistant to other antibiotics. The candidate is currently undergoing its phase 3 clinical trial to evaluate its effectiveness in treating uncomplicated and complicated urinary tract infections as well as intra-abdominal infections.

The firm’s drug candidate, sulopenem, is the only IV and oral branded penem available worldwide. The FDA accepted the firm’s NDA for its sulopenem candidate for the treatment of uncomplicated UTIs. As of 2021, Iterum Therapeutics Plc. had also partnered up with Eversana, which would help in the effective and efficient distribution of sulopenem once the drug is available for prescribing.

Iterum Therapeutics (ITRM), closed Tuesday’s trading session at $0.7449, up 40.2561%, on 44,833,605 volume. The average volume for the last 3 months is 42.292M and the stock's 52-week low/high is $0.451/$2.995.

My Size (MYSZ)

TraderPower, StockMarketWatch, StockHideout, Broad Street, BUYINS.NET, QualityStocks, Penny Stock Titans, MarketBeat, OTCBB Journal, Penny Picks, Penny Pick Finders, PCG Advisory, OTCtipReporter, Penny Stock Craze, Investor News Source, Faisam Trader, Damn Good Penny Picks, BullFreak, InvestorSoup, Beacon Equity Research, Penny Stock General, PennyStockProphet, PennyStockScholar, Planet Penny Stocks, Profitable Trader Authority, Promotion Stock Secrets, ProTrader, Shiznit Stocks, Stock Preacher, StockOnion, Stockwire, StreetAuthority Daily, SuperStockTips and Penny Stock Finder reported earlier on My Size (MYSZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

My Size Inc. (NASDAQ: MYSZ) (FRA: 2YJ1) is a firm that provides solutions for online retailers and consumers. It is engaged in the development and commercialization of mobile device measurement solutions for the e-commerce DIY (do-it-yourself), shipping and parcel delivery and apparel/fashion industries in Israel.

The firm is headquartered in Airport City, Israel and was incorporated in 1999, on September 20th by Ronen Luzon. Prior to its name change in January 2014, the firm was known as Knowledgetree Ventures Inc. It mainly focuses on the fashion and e-commerce industry.

The enterprise uses sophisticated technology and algorithms to develop measurement technology with broad applications. It provides an application that allows users to create an online profile based on their personal measurements, to ensure they get the right fit. The application, known as MySizeID, is secure and its information can be used by online retailers to ensure that the measurements are correct. This application provides a solution that minimizes returns from online purchases for online retailers. The company’s other products include In-Store Shopping Tool, Cross-Site search feature and another application; a smart measuring tape, which enables users to measure objects accurately and instantly using their phones, called SizeUp. The company also offers a parcel measurement app that enables consumers to measure their parcel size using their phone, calculate shipping costs and set a pick-up time for their parcel. This app is called BoxSize.

The company recently launched an avatar solution that mirrors the bodies of online shoppers for a gamified, virtual try on experience. This will allow consumers to experience a fitting process without having to provide personal photos in order to obtain their size. This move will further increase the firm’s popularity in the market, which will significantly boost its growth.

My Size (MYSZ), closed Tuesday’s trading session at $1.58, up 36.2069%, on 272,243,445 volume. The average volume for the last 3 months is 272.243M and the stock's 52-week low/high is $0.8851/$2.97.

Progenity (PROG)

Schaeffer's, StreetInsider, QualityStocks, MarketBeat, TradersPro, Trades Of The Day and InvestorPlace reported earlier on Progenity (PROG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Progenity Inc. (NASDAQ: PROG) (FRA: 4ZU) is a biotechnology firm that is engaged in the development and commercialization of specialized diagnostic and molecular testing products to clinicians in the U.S.

The firm has its headquarters in San Diego, California and was incorporated 2010 by Harry Stylli and Paul W. Hawran. Prior to its name change in November 2013, the firm was known as Ascendant MDX Inc. It serves consumers in the U.S. and operates as part of the health care sector, in the medical and diagnostic equipment and devices sub-industry.

The company offers in vitro molecular tests that have been developed to improve lives by providing information that is used to guide physicians and patients when making medical decisions during important life stages.

Its products include a hereditary cancer screening test that looks for genes linked to inherited risk of cancers like pancreatic, colorectal, ovarian and breast cancer known as Riscover; a test that screens for carrier status of hereditary ailments in early pregnancy known as Preparent and a non-invasive prenatal screening test that is provided to women in early pregnancy that screens for chromosome abnormalities like trisomy 13, 18 and down syndrome known as Innatal. In addition to this, it also offers a preeclampsia rule-out test called Preecludia and a non-invasive test for individuals at risk for rare single gene disorders known as Resura. Furthermore, the enterprise is engaged in the development of therapies for gastro-intestinal-related disorders, like PGN-OB2, PGN-600 and PGN-001.

The company recently launched its strategic transformation into becoming a biotech firm, which will focus on its R&D pipeline. This move will position the business better for future growth while also helping transform and address significant markets by enhancing patient outcomes, which will in turn attract investments into the company.

Progenity (PROG), closed Tuesday’s trading session at $3.99, up 18.0473%, on 253,896,054 volume. The average volume for the last 3 months is 253.896M and the stock's 52-week low/high is $0.657/$8.20.

Waitr Holdings (WTRH)

InvestorPlace, MarketClub Analysis, MarketBeat, TradersPro, StockMarketWatch, QualityStocks, BUYINS.NET, The Online Investor, Schaeffer's, Wealth Insider Alert, Trades Of The Day and StreetInsider reported earlier on Waitr Holdings (WTRH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Waitr Holdings Inc. (NASDAQ: WTRH) (FRA: 10W) is focused on providing and operating an online ordering technology platform.

The firm has its headquarters in Lafayette, Louisiana and was incorporated in 2008 on November 13th by Christopher Meaux. It operates under the consumer discretionary sector, as part of the mobile food services industry, in the leisure facilities and services sub-industry. The firm, which operates as a restaurant, serves consumers in the U.S. There are two companies under its corporate family.

The company partners with national and regional chains in mid-size and small markets as well as independent local restaurants. Its Bite Squad and Waitr mobile applications offer diners, drivers, connecting restaurants, dine-in options, carryout and delivery services. Here, individuals can order food from restaurant partners for delivery and pick-up via a network of drivers. The platform benefits the consumer by offering a single location to browse local menus and restaurants, track delivery and order status and securely store prior payment information and orders for convenience and ease of use.

As of December 2020, the firm had about 20,000 restaurants in seven hundred cities on its platforms. It recently revealed its strategic initiative to change its visual identity and name in a rebrand, which will be effected in the coming year or so. This move reflects its commitment to innovation and continued expansion into new delivery verticals. The company’s CEO noted that they were interviewing branding firms to determine a corporate brand and name that reflected their long-term business strategy. This will encourage more investments into the firm.

Waitr Holdings (WTRH), closed Tuesday’s trading session at $2.05, up 43.3566%, on 70,358,760 volume. The average volume for the last 3 months is 64.385M and the stock's 52-week low/high is $0.8009/$4.57.

Claritas Pharmaceuticals (KALTF)

We reported earlier on Claritas Pharmaceuticals (KALTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Claritas Pharmaceuticals Inc. (OTC: KALTF) (FRA: S6VA) is a clinical-stage specialty pharmaceutical firm that is engaged in the development and commercialization of therapies for patients with unmet medical needs.

The firm has its headquarters in San Rafael, California and was incorporated in 2004, on October 15th by Seth Yakatan. Prior to its name change in April 2021, the firm was known as Kalytera Therapeutics Inc. It serves consumers across the globe.

The company’s expertise and professional network allows them to create groundbreaking opportunities that address challenges associated with drug development. The company is party to a strategic collaboration with Salzman Group Ltd, which entails the manufacture of its R-107 formulation, as well as the design and completion of clinical studies that show the effectiveness and safety of this formulation in the treatment of the coronavirus infection.

The enterprise’s product pipeline comprises of its patented nitric oxide-releasing compound dubbed R-107, which has been developed to treat the coronavirus infection. This compound was designed to supplement the body’s natural nitric oxide release and considerably strengthen the body’s ability to fight viruses. In addition to this, the enterprise is also developing a formulation known as CLA-1816 to offer effective pain reduction without the risks associated with opioid analgesics, like respiratory suppression and addiction.

The company is set to acquire an exclusive license to develop and commercialize a new proprietary drug developed by Biozeus Pharmaceuticals SA, known as BZ371B. The formulation has been designed to prevent and treat pulmonary ailments. This move will position the company as a leader in nitric oxide pharmaceuticals, which may bring in more investments into the company.

Claritas Pharmaceuticals (KALTF), closed Tuesday’s trading session at $0.2, off by 4.943%, on 14,310 volume. The average volume for the last 3 months is 14,310 and the stock's 52-week low/high is $0.03/$0.70.

Salem Media Group (SALM)

The Online Investor, Zacks, StreetAuthority Daily, MarketBeat, Wall Street Resources, TradersPro, QualityStocks, Forbes, TopStockAnalysts, Investing Lab, InvestorPlace, Market FN, Marketbeat.com, MarketClub Analysis, Money Morning, SmallCapVoice, Daily Dividends, Street Insider, StreetInsider, Streetwise Reports, The Best Newsletters, The Next Hot Stock, Tiny Gems, Trading Concepts and StockMarketWatch reported earlier on Salem Media Group (SALM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Salem Media Group Inc. (NASDAQ: SALM) is a multimedia firm that is focused on providing media specializing in conservative and Christian content.

The firm has its headquarters in Irving, Texas and was incorporated in 1986 by Edward G. Atsinger III and Stuart W. Epperson. Prior to its name change in February 2015, the firm was known as Salem Communications Corp. It serves consumers around the globe.

The company operates through the Publishing, Digital media and Broadcast segments. The publishing segment is made up of print and digital magazines, self-publishing services and book publishing services. The digital media segment provides video and audio streaming, e-commerce, investing and health-themed content, conservative and Christian, as well as other resources digitally through the internet. On the other hand, the broadcast segment operates and owns radio stations in various metropolitan markets, which includes local and national programming content. Its Salem Radio network is a national radio network which provides syndicated talk, music and new programming to affiliated radio stations.

The enterprise also publishes digital newsletters that offer non-individualized investment strategies and market analysis. It also operates church product websites which include Playblackmedia.com, Hyperpixels.com, JourneyBoxMedia.com, Children-Ministry-Deals.com, Youthworker.com, ChristianJob.com, Preaching.com, WorshipHouseKids.com and ChurchStaffing.com, among many others. In addition to this, it provides a print-on-demand self-publishing service known as Xulon Press as well as publication of history, Christian and conservative books. Furthermore, it offers digital marketing services and the Mill City Press that publishes books.

The firm recently launched the Doug Collins Podcast, which will extend its consumer reach and encourage more investments into the firm.

Salem Media Group (SALM), closed Tuesday’s trading session at $3.63, off by 17.1233%, on 1,670,193 volume. The average volume for the last 3 months is 1.637M and the stock's 52-week low/high is $0.7828/$6.82.

Biotricity Inc. (BTCY)

QualityStocks, MarketBeat, SmallCap Network, Broad Street, Fierce Analyst, AwesomeStocks, Small Cap Firm, StockStreetWire, StockWireNews, TradersPro, PoliticsAndMyPortfolio, SECFilings.com News, SmallCapNetwork, Wealth Insider Alert, Stock News Now, StocksEarning, InvestorPlace, Insider Financial and Wall Street Mover reported earlier on Biotricity Inc. (BTCY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Biotricity Inc. (NASDAQ: BTCY) is a medical technology firm that is engaged in the provision of biometric data monitoring solutions to the medical and consumer markets.

The firm has its headquarters in Redwood City, California and was incorporated in 2012, on August 29th by Peter McGldrick and Waqaas Al-Siddiq. It serves consumers in Canada and the United States.

The company’s research and development division is focused on the preventive healthcare market. Its vision is to put health management into the hands of every patient by providing diagnostic and post-diagnostic solutions for chronic and lifestyle ailments.

The enterprise’s products include its mobile cardiac telemetry device, known as Bioflux, which is an integrated electrocardiogram device and software solution that offers real-time transmission and monitoring of an individual’s ECG information. This device can also detect arrhythmias. It also produces Biocare health and a personal heart monitor known as Bioheart. In addition to this, it offers a virtual clinic platform known as Biocare Telemed, which allows physicians to offer patient care remotely. Furthermore, the enterprise is expanding medical-grade monitoring into the consumer market through its Biolife solution, which helps users to manage chronic conditions. This health and lifestyle solution is made up of a device that monitors an individual’s heart-rhythm, physical activity, temperature, calories and respiration, among other things.

The company recently announced that it would be releasing its Biocare Cardiac application for people at risk of or with cardiovascular disease. The application has been designed for use with the Galaxy Watch4 series by Samsung. This partnership and the application’s launch not only helps cardiovascular patients to take control of their condition but also extend the firm’s consumer reach, which will have a positive impact on the company’s growth and investments.

Biotricity Inc. (BTCY), closed Tuesday’s trading session at $4.35, up 1.3986%, on 696,969 volume. The average volume for the last 3 months is 696,969 and the stock's 52-week low/high is $0.67/$4.45.

Biophytis SA (BPTS)

We reported earlier on Biophytis SA (BPTS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Biophytis SA (NASDAQ: BPTS) (FRA: 6XB) is a clinical-stage biotechnology firm that is engaged in the development of therapies which enhance functional outcomes and slow degenerative processes for patients with age-related illnesses.

The firm has its headquarters in Paris, France and was incorporated in 2006, on September 15th by René Lafont and Stanislas Veillet. It operates as part of the scientific research and development services industry. The firm has two companies in its corporate family and serves consumers in France.

The company’s objective is to become a leader in the emerging aging science field by introducing life-changing therapies that meet the growing number of patients’ needs. It is party to a collaboration agreement with AFM-Telethon, which entails the development of its BIO101 formulation for the treatment of Duchenne muscular dystrophy.

The enterprise’s product pipeline comprises of therapies that target and activate major biological resilience pathways which may counteract and protect against the effects of multiple environmental and biological stresses that cause age-related ailments. Its lead product is an orally administered small molecule dubbed BIO101, which has been developed to treat neuromuscular ailments like Duchenne muscular dystrophy and sarcopenia. It also develops another orally administered molecule known as BIO201, for the treatment of retinal illnesses like Stargardt disease and dry age-related macular degeneration.

The firm recently appointed a new Chief Medical Officer who brings with him extensive experience in drug development from both global biotech and pharma companies. The firm is focused on making progress in its clinical programs, with its BIO101 formulation set to reach the market in the near future.

Biophytis SA (BPTS), closed Tuesday’s trading session at $6.27, even for the day, on 197 volume. The average volume for the last 3 months is 184 and the stock's 52-week low/high is $6.00/$18.50.

Troika Media Group (TRKA)

Small Cap Firm, Mega Stock Alerts, Fierce Analyst, Broad Street, StockWireNews and MarketClub Analysis reported earlier on Troika Media Group (TRKA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Troika Media Group Inc. (NASDAQ: TRKA) is an advertising and marketing firm that leverages data and technology to deliver analytics, media, marketing and integrated branding solutions.

The firm has its headquarters in Los Angeles, California and was incorporated in November 2003. Prior to its name change in July 2017, the firm was known as M2 nGage Group Inc. It serves consumers in the United Kingdom and the United States.

The company’s operating units include Mission Media USA Inc., Mission-Media Holdings Ltd, Mission Culture LLC, Troika Design Group Inc. and Troika Services Inc. It provides solutions to clients seeking a holistic approach to meeting communications, experiential marketing and brand strategy needs.

The enterprise provides design, animation and post-production studio services; digital and physical experiential, crisis management, public relations, marketing strategy, brand fundamentals development services; original music and sonic branding, content creation, brand experience and fan engagement, advertising and sponsorship integration, 360 brand design, brand strategy, market research and insights, design and branding, and strategic media buying and planning services. It also provides media content for advertising opportunities, sponsorship partnerships, hospitality customers and events. The enterprise serves non-profit organizations as well as the automotive, sports, tech, telco, consumer goods, entertainment, pharmaceuticals, beverage alcohol, jewelry/watches, beauty and fashion industries.

The company recently announced its latest financial results, with its CEO noting that the firm was focused on maintaining the high quality of relationships and services with its clients, which positions them for significant growth. It is also focused on raising its margin potential and lowering its expense base.

Troika Media Group (TRKA), closed Tuesday’s trading session at $2.75, up 50.2732%, on 19,125,912 volume. The average volume for the last 3 months is 18.879M and the stock's 52-week low/high is $1.20/$4.00.

The QualityStocks Company Corner

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF)

The QualityStocks Daily Newsletter would like to spotlight Mydecine Innovations Group Inc. (MYCOF).

Mydecine Innovations Group Inc. (NEO: MYCO) (NASDAQ: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health disorders and addiction. Founded in 2020 on the guiding principle that there is a significant unmet need and lack of innovations in the mental health and therapeutic treatment environments, Mydecine is dedicated to efficiently developing innovative first- and second-generation novel therapeutics to treat PTSD, addiction and other mental health disorders.

Mydecine’s business model combines clinical trials and data outcome, technology and scientific and regulatory expertise with a focus on psychedelic therapy underpinned by novel molecules with differentiated therapeutic potential. By collaborating with some of the world’s foremost authorities connected by best practices, Mydecine aims to responsibly fast-track the development of new medicines across its platforms, ultimately changing the way we treat mental health disorders. The company seeks to bridge the gap between the needs of patients and what the mental health care system currently provides.

Mydecine Innovations Group is headquartered in Denver with international offices in Canada and Europe.

Research and Technology

The invention and development of novel psychedelic and non-psychedelic molecules for medical use is an important part of Mydecine’s research strategy. The company uses molecules found in nature as building blocks to create improved second-generation drugs. This portfolio of new drugs represents major improvements to existing natural products and synthetics, including enhanced safety, efficacy, stability and dosing, as well as reduced side effects.

The goal of creating these improved second-generation compounds is to enable safer, more effective treatments for patients, along with improved management of dosage and drug behavior for clinicians. Mydecine believes the multibillion-dollar market for mental health and addiction disorder medicines will soon be disrupted amid a resurgence of the study into psychedelics and data showing the immense benefits of these forms of medicine.

The company currently has four lead drug candidates which include various enhancements such as improved controllability, delivery mechanisms, safety, stability and shelf-life. The drug candidates are in clinical trials or in pre-trial stage as potential treatments to aid PTSD, substance abuse and smoking cessation.

Mindleap Health is a wholly owned subsidiary of Mydecine. The Mindleap platform is a virtual community that aims to foster the conscious and responsible adoption of psychedelic medicine into inner wellness. Users access the platform through the Mindleap app. Mindleap provides users with inner wellness resources to assist them in their daily mental-health journeys. The platform also seeks to support the conscious and trustworthy adoption of psychedelics into a widely accepted approach to mental health and inner wellness.

Market Outlook

The global smoking cessation market is expected to reach $63.99 billion by 2026, growing at a CAGR of 16.9 percent from 2018 to 2026. The market for psychedelic therapeutics is in its very early stages. Estimates of current market value and forecasts of expected value in future years are all over the map. Market forecasts range from $6.5 billion by 2030 with a CAGR of 15 percent, to more than $69 billion as soon as 2025, at a CAGR of 8.2 percent. What is clear is that interest in psychedelic therapeutic drugs is expanding rapidly.

Management Team

Joshua Bartch is Chief Executive Officer and Chairman of Mydecine Innovations Group. He is an experienced entrepreneur who co-founded AudioTranscriptionist.com and founded Denver-based dispensary Doctors Orders in 2009. He also founded a boutique investment firm that operated throughout the U.S. and Canadian markets. In 2014, Bartch co-founded Cannabase.io, the USA’s most significant and sophisticated legal cannabis wholesale platform.

Dr. Rakesh Jetly, OMM, CD, MD, FRCPC, is the Chief Medical Officer of Mydecine. He was formerly Chief of Psychiatry for the Canadian Armed Forces, retiring in 2021 with the rank of colonel after 31 years of service. He began his career as a general duty medical officer and flight surgeon and spent his final 20 years of service as a psychiatrist. He maintains academic appointments at Dalhousie University and The University of Ottawa. He is the inaugural CF Brigadier Jonathan C. Meakins CBE, RCMAC, Chair in Military Mental Health at the Royal Ottawa Hospital.

Robert Roscow is Chief Scientific Officer of Mydecine. As a geneticist, he has spent his academic and professional careers looking for valuable and unique medicinal molecules found in nature. His innovations were applied at Canopy Growth and ebbu, where he ran those companies’ genetics divisions. He has leveraged his expertise to maximize industrial production of cannabinoids in a pharmacological context, resulting in multiple patent filings.

Damon Michaels is Chief Operating Officer of Mydecine. He previously consulted for various hemp businesses through his company, Emerald Baron. Before that, he served as GM for ebbu, the leading multi-platform cannabinoid research and technology firm based in Colorado. He has held leading roles with multiple large brands throughout the cannabis vertical. He also developed a national snowboard brand.

Mydecine Innovations Group Inc. (MYCOF), closed Tuesday’s trading session at $0.2714, up 0.798514%, on 258,394 volume. The average volume for the last 3 months is 258,394 and the stock's 52-week low/high is $0.1257/$2.20.

Recent News

FingerMotion Inc. (OTCQX: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (OTCQX: FNGR) .

  • U.S.-based FingerMotion has been pursuing opportunities to provide text and multimedia message services in China, whose population is expected to exceed 1.4 billion people this year
  • FingerMotion is expanding into a third channel of operations with the development of its trademarked big data platform Sapientus, and expects revenues from the tech platform to eventually exceed its SMS and MMS message services
  • The company recently reported its Q2 financials, noting a 25 percent YOY quarterly growth in revenues attributed to SMS and MMS services, and an overall quarterly revenue growth to $5.39 million
  • China is encouraging development of its insurance industry services, providing increased opportunities for leading global insurers such as Pacific Life
  • Pacific Life Reinsurance finalized a contract with FingerMotion for Sapientus’ services earlier this year, strengthening FingerMotion’s position in supporting the insurtech industry

Communications and big data technology platform builder FingerMotion (OTCQX: FNGR) is welcoming signs of growth in its newly released Q2 report. The China-focused enterprise reported quarterly revenue of $5.39 million, which included a 25 percent year-over-year quarterly growth in its short and multimedia messaging (SMS and MMS) business revenue of $0.73 million. FingerMotion (OTCQX: FNGR), a mobile data and services company, through its subsidiary Shanghai JiuGe Information Technology Co. Ltd., has trademarked two new brands. The two trademarked brands — Ji Shi Fu and Baowo — are designed to support the company’s planned underwriting of an innovative device protection program for telecom customers in China. According to the company, this maintenance program could include up to hundreds of stores in more than 10 provinces; potential products and services include broken mobile phone screens, accidental damage repairs and compensation, older device trade-ins and other services. The program could also spark growth, including adding new users and opening new revenue channels. The company noted that it anticipates these new brands will be added to its existing China telecom systems by early 2022, with beta testing initially taking place in the Shanghai, Guangdong, Anjui, Zhejiang and Henan provinces and cities. "This latest development demonstrates the flexibility of our business model to explore ways to monetize our vast active user base," said Fingermotion CEO Martin Shen in the press release. “We are delighted to commence our beta testing on this mobile device protection product later this month and believe this will eventually represent another significant revenue stream.” To view the full press release, visit https://ibn.fm/7cMFR

FingerMotion Inc. (OTCQX: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (https://ibn.fm/zfwy9).

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (https://ibn.fm/TGo7D).

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Tuesday’s trading session at $6.8, up 0.890208%, on 9,551 volume. The average volume for the last 3 months is 9,551 and the stock's 52-week low/high is $3.22/$17.00.

Recent News

Nemaura Medical Inc. (NASDAQ: NMRD)

The QualityStocks Daily Newsletter would like to spotlight Nemaura Medical Inc. (NASDAQ: NMRD).

The world’s largest and most powerful tech companies –Alphabet (NASDAQ: GOOG)Amazon (NASDAQ: AMZN) and Apple (NASDAQ: AAPL) – are targeting an opportunity in health care that’s just too big to ignore – diabetes. Almost a third of the entire U.S. population – more than 100 million people in this country alone – are living with diabetes or are at high risk for the disease. Diabetes makes it difficult for the body to process sugar (glucose) and can lead to serious health issues and death. With $1 of every $4 of health care costs in the U.S. now spent on caring for people with diabetes, these tech giants are looking to snag a share of the multi-trillion-dollar global diabetes markets through innovation. Tech continues to provide creative solutions to better manage chronic diseases like diabetes. Nemaura Medical Inc. (NASDAQ: NMRD) has developed sugarBEAT(R) – a wearable, non-invasive and flexible continuous glucose monitor patch designed to help people with diabetes and prediabetes manage their glucose levels. sugarBEAT(R) consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with a smartphone app displaying glucose readings at five-minute intervals for periods of up to 24 hours. Users don’t have to draw blood samples or prick their fingers multiples times each day and can wear the patch on whatever days they choose. 

Nemaura Medical Inc. (NASDAQ: NMRD) is a medical technology company developing affordable diagnostic and digital tools for chronic disease management. Its flagship product, sugarBEAT®, is a wearable, non-invasive and flexible Continuous Glucose Monitor (CGM) designed to help people with diabetes and prediabetes manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading.

sugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with a smartphone app displaying glucose readings at five-minute intervals for periods of up to 24 hours. One of the great advantages of the product, apart from the fact that users no longer need to draw blood samples or prick their fingers, is that a person can wear the CGM patch on whatever day they choose. Existing CGM devices must be implanted under the skin. Wearable disposability is a unique feature of sugarBEAT and a world first, opening up vast potential for changing the way people manage their chronic disease conditions. sugarBEAT received CE mark clearance in May 2019, allowing it to be marketed and sold within the European Union as a Class 2b Medical Device. The company submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration in 2020 which is currently under review.

Founded in 2011, Nemaura set out to develop a single platform technology to measure blood markers at the surface of the skin. Since then, the company has evolved with the creation of wearable technologies and digital health care solutions that encourage and empower people to take charge of their own health and well-being. Nemaura’s skin surface blood monitoring technology has allowed the company to create additional products, which are in the pipeline, such as Lactate Monitoring.

Technologies

Digital Solutions for Weight Loss and Potential Reversal of Type 2 Diabetes

This is a digital program that comes with more than a decade of clinical evidence demonstrating excellent efficacy. The company has combined this with its glucose-monitoring platform to bring a product to market to help people with diabetes manage their condition and potentially reverse Type 2 diabetes.

Glucose Monitoring Solutions for Diabetes Prevention and Reversal

Over 420 million people worldwide are living with diabetes, and prediabetes cases total almost three times that number. Undoubtedly, diabetes is an urgent global health crisis. Combining clinical research with patient-friendly technology, Nemaura’s sugarBEAT product delivers a non-invasive, affordable and flexible method of blood glucose tracking for improved diabetes management.

Continuous Lactate Monitoring for Athletic Performance (Non-Medical)

Lactic acid is a key performance indicator for the body and a guide to how well muscles react to long term exertion and recovery. Well-trained athletes and those who regularly engage in sports are very efficient at faster lactate ‘recycling’ for extra energy (ATP). Nemaura expects to launch its lactate sensor to the sports and personal training market in 2022.

Continuous Lactate Monitoring in Disease State (Medical)

An increase in blood lactate levels is also a marker of critical disease states. Recent publications have indicated the presence of elevated lactate levels in patients with COVID-19 infection. Nemaura has developed a lactate sensor that is being integrated into the company’s platform, which will be submitted for regulatory clearance upon completion of requisite clinical studies.

Continuous Temperature Monitoring for Viral Infection Detection and Disease Progression

A person’s body temperature says a lot about their health. Several diseases, including COVID-19, are characterized by an increase in body temperature, so temperature monitoring is a vital tool in the detection, diagnosis and prevention of the spread of disease. Nemaura is expecting to submit this adaptation of the device for regulatory clearance in 2022.

Market Opportunity

Obesity and diabetes are two of the major drivers of the current chronic disease epidemic. According to the International Diabetes Federation, there are more than 463 million people living with diabetes worldwide. In the U.S., about 28,000 people are diagnosed with diabetes every week, and more than 34 million suffer from diabetes. Another 88 million Americans have prediabetes. Other industrialized countries show similar numbers based on their populations. In the U.K., 4.8 million people have diabetes, with another diagnosed every two minutes. In Germany, 9.5 million have diabetes, with almost half estimated to be undiagnosed and so at greater risk.

On average, employers and insurers spend more than $9,000 annually on health care for an employee with diabetes, compared to $1,600 annually for a healthy employee. In the U.S. alone, more than $760 billion was spent on diabetes-related health care expenditures during 2019. Nemaura is positioned at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50-plus billion prediabetic market, and the wearable health-tech sector for weight loss and wellness applications forecast to hit $60 billion by 2023.

Management Team

Dr. Faz Chowdhury has been CEO and chairman of the board of Nemaura Medical since 2013. He has more than 20 years of experience in the pharmaceutical and medical devices industry, taking products from concept to commercial launch. He is sole inventor on more than 100 granted and pending patents and has authored textbook chapters on nano-biosciences for Wiley and Elsevier. He holds a master’s degree in microsystems and nanotechnology from Cranfield University, and a doctorate from the University of Oxford in nano-medicine and drug delivery.

Justin Mclarney is CFO at Nemaura. He most recently was the Senior Director, International Finance at Lands’ End Inc. He also worked for Office Depot as Senior Director of Finance for the largest business unit within the European group. Prior to that, he spent more than 10 years in practice, the majority of which was with Ernst & Young LLP.

Dr. Fred Schaebsdau is Vice President of Strategy & Strategic Alliances at Nemaura. He has more than 15 years of executive experience in the CGM, blood glucose monitoring and insulin delivery industries, including time with Abbott Diabetes Care, as General Manager of Dexcom Germany and at Roche Diabetes Care, where he was Senior Vice-President, Head of Global Strategy and Business Development. The firm he founded is the exclusive distributor in Europe, the Middle East and Africa of UniStrip®, the world’s first generic blood glucose test strip. He is licensed to practice medicine in the U.S. and Germany.

David Scott is Director of Commercial Development and Licensing at Nemaura. He is a trained chemist with over 35 years of experience in the pharmaceutical industry, including deal brokering, marketing, strategic planning, finance, business development and acquisitions. He has also provided licensing training for a number of multinational pharma companies and training organizations and is the author of best-selling report Scrip’s Practical Guide to Pharmaceutical Licensing.

Nemaura Medical Inc. (NASDAQ: NMRD), closed Tuesday’s trading session at $5.94, up 2.0619%, on 13,280 volume. The average volume for the last 3 months is 13,280 and the stock's 52-week low/high is $3.3013/$17.40.

Recent News

Excellon Resources Inc. (NYSE American: EXN) (TSX: EXN) (FSE: E4X2)

The QualityStocks Daily Newsletter would like to spotlight Excellon Resources Inc. (NYSE American: EXN) (TSX: EXN) (FSE: E4X2).

Excellon Resources (NYSE American: EXN) (TSX: EXN) (FSE: E4X2) today announced results from underground drilling at the Platosa Mine in Durango, Mexico. Among the highlights, the company reported high-grade results from the 623, NE-1, NE-1S and Pierna mantos, with diamond drilling results from underground. According to the update, underground drilling continues to define and delineate mineralization to support mine planning, and follow-up drilling on vertical zone intersected in hole EX21UG690 is underway with assays pending. “Drilling at Platosa continues to define and extend high-grade mineralization ahead of production,” said VP of Exploration Jorge Ortega in the news release. “We continue to focus on infill drilling to support planning for upcoming and future production, as well as testing the recently discovered high-grade zone — the 817 zone — below manto 623. We have now drilled an additional 20 holes on the 817 zone with assays pending. This zone appears to have a vertical orientation and has the potential to open up a more vertical dimension to the deposit.” To view the full press release, visit https://ibn.fm/qeR8T

Excellon Resources Inc. (NYSE American: EXN) (TSX: EXN) (FSE: E4X2) (“Excellon” or the “Company”) is a silver and base metals producer with precious metal exploration and development projects in Mexico, Idaho and Germany. Since being founded in 1987, the Company has been advancing a precious metals growth pipeline focused on creating wealth for its stakeholders by realizing strategic opportunities in the silver and gold markets.

Excellon is an active and influential member of the Mining Association of Canada (“MAC”). The Company implements a practical, best-in-class management system that addresses the safety, health, security, environmental and community aspects of its operations, per the UN Sustainable Development Goals. On each project, the Company incorporates MAC’s Towards Sustainable Mining Initiatives and other world-class best practices with the objective of constantly improving its safety systems, training and hazard recognition.

Precious Metals Growth Pipeline

The Company is advancing a precious metals growth pipeline that includes: Platosa, Mexico’s highest-grade silver mine since production commenced in 2005; Kilgore, a high-quality gold development project in Idaho with strong economics and significant growth and discovery potential; and an option on Silver City, a high-grade epithermal silver district in Saxony, Germany, with 750 years of mining history and no modern exploration.

Maintaining and developing this pipeline presents the Company with enhanced opportunities in the expanding precious metals market, which was valued at $193.3 billion worldwide in 2020 (https://nnw.fm/6nv5f). This market is expected to increase at a compound annual growth rate (“CAGR”) of 9% from 2020 to 2027, resulting in an estimated $362.1 billion market size in 2027 (https://nnw.fm/6nv5f). Global market demand was calculated at 22,581.8 tons in 2020 and is expected to grow to 36,501.1 tons in 2027, achieving a CAGR of 3.5% (https://nnw.fm/6nv5f).

Excellon reported strong results in terms of both production and average pricing at the end of Q4 2020, including:

  • Silver – 355,581 oz – $24.46
  • Lead – 2,223,465 lbs. – $0.87
  • Zinc – 2,452,728 lbs. – $1.21

Compared to Q4 2019, Excellon’s silver production increased by 37%, lead increased by 32% and zinc increased by 19% in Q4 2020 (https://nnw.fm/4C0P7).

Platosa Mine – Silver, Lead, Zinc – Production, Development & Exploration

The Platosa Mine is located 5 km north of Bermejillo, Durango, Mexico, on a 14,000-hectare property. The mine commenced production in 2005 as an underground operation and is 100% owned and operated by Excellon. The Company is mining massive sulfide ores rich in silver, lead and zinc from a series flat-lying massive sulfide bodies (mantos) in a carbonate replacement deposit system. Historically, the mining method was a modified room and pillar method, which transitioned to cut-and-fill in recent years and overhand-cut-and-bench in 2020. The ore produced from the mine is transported 200 km south for processing at the Company’s 100% owned Miguel Auza mill.

Kilgore Project – Gold – Exploration & Resource Growth

The Kilgore Project is located in Clark County, situated in eastern Idaho in the United States. The project area is 100% owned and operated by Excellon. While still in the exploration and development phase, the primary target on the 13,627-acre site is an epithermal gold system. The property itself has historical mining that dates back to the 1930s, with modern mineral exploration beginning in the 1980s. The Kilgore Project displays characteristics similar to Kinross Gold’s Round Mountain Mine, which has produced more than 15 million ounces of gold since operations began in 1977.

Evolución Project – Mineral Processing, Resource Growth & Exploration

The Evolución Project is located in Miguel Auza, Zacatecas, Mexico, and hosts a large gold, silver, lead and zinc epithermal within a 45,000-hectare property that is 100% owned by Excellon. The site includes a processing facility with a mill and flotation circuit which processes ore from Excellon’s Platosa mine. The facility has a capacity of 800 tons per day, with a 650 ton-per-day ball mill in operation and a second 150 ton-per-day ball mill on standby. Excellon is looking at opportunities for toll milling, expansion and economic study of the mineral resource and grassroots exploration. Importantly, the project covers an unexplored 35-kilometer strike of the Fresnillo silver trend, the richest silver belt in the world.

Silver City Project – Exploration

Excellon holds an option to acquire the 16,400-hectare Silver City Project in Saxony, Germany. Initial drilling results in 2020 confirmed the presence of a high-grade, district-scale epithermal silver system over more than 12 kilometers of strike. The Company is now focused on defining wider zones of mineralization (https://nnw.fm/jMah9). Silver City was mined from the 11th to late-19th century, until Germany moved off the silver standard in 1873. The deposits in the area were exceptionally high grade, with historical records indicating grades well in excess of 1,000 g/t silver.

Oakley Project – Exploration

The Oakley Project, located in Oakley, Idaho, is an exploration project with land holdings of approximately 7,000 acres. The project hosts gold-silver, epithermal hot spring-type mineralization at two targets: Blue Hill Creek and Cold Creek, and detachment-related gold-silver mineralization at Matrix Creek. The Company has granted Centerra (U.S.) Inc. an option to earn in to a 70% interest by, among other things, spending up to US$7 million in exploration expenditures on the project prior to May 2026.

Management Team

Brendan Cahill is the President & Chief Executive Officer of Excellon Resources Inc. He was previously Vice President Corporate Development of Pelangio Exploration Inc., a junior gold exploration company active in Ghana, West Africa. Mr. Cahill is a board member of the Mining Association of Canada, Group Eleven Resources Ltd., and Kore Mining Inc. He holds a law degree from the University of Western Ontario and an undergraduate degree from the University of Toronto.

Alfred Colas is the Company’s Chief Financial Officer. Most recently, he held the title of CFO of Arch Corp., a Toronto-based private-equity investment firm. Mr. Colas has over 18 years of experience in the mining industry. He is a sitting board member for a housing corporation affiliated with the University of Toronto and is a Chartered Professional Accountant. Mr. Colas completed a Bachelor of Commerce at the University of Toronto.

Paul Keller is Excellon’s Chief Operating Officer. He has over 30 years of industry experience in mining and mine development operations. He previously served as the Senior VP of Major Projects and COO of Trevali Mining. He has experience in building mines from greenfield through permitting, design and operation. Mr. Keller holds a Bachelor of Engineering – Mining from Laurentian University.

Ben Pullinger is the Senior Vice President Geology & Corporate Development for Excellon. Ben brings over 15 years of experience in advancing projects from early stage exploration through to production. Most recently, he was Vice President Exploration at Roxgold Inc., where he made a significant contribution toward growing the 55 Zone at Yaramoko Project into a producing mine. Mr. Pullinger serves on the board of Orford Mining. He is a Professional Geologist (Ontario) and holds an Honors Degree in Geology from the University of Johannesburg.

Excellon Resources Inc. (EXN), closed Tuesday’s trading session at $1.55, up 0.649351%, on 39,266 volume. The average volume for the last 3 months is 39,265 and the stock's 52-week low/high is $1.25/$3.90.

Recent News

StraightUp Resources Inc. (CSE: ST)

The QualityStocks Daily Newsletter would like to spotlight StraightUp Resources Inc. (CSE: ST).

StraightUp Resources (CSE: ST) (OTCQB: STUPF)  today announced its entry into a right of exclusivity agreement (“ROE”) with Premier Silver Corp. (“Premier” or “PSC”). According to the update, the ROE provides that StraightUp and Premier will exclusively negotiate an agreement for a period of 60 days, whereby StraightUp will acquire all of the outstanding shares of Premier from the current shareholders. Premier was formed by a group with a combined 100-plus years of experience in the junior mining industry, raising in excess of $700 million in capital and creating more than $1 billion in shareholder value. PSC, in 2020, concluded commercial discussions with Buenaventura Mining Company Inc. (NYSE: BVN) and completed the acquisition of one of the largest silver mining land packages in Peru with over US$120 million in capitalised expenditures: the Mallay Mine & Processing Plant and associated exploration and development assets. To view the full press release, visit https://ibn.fm/Wcs3V

StraightUp Resources Inc. (CSE: ST) is a public company engaged in the business of mineral exploration and the acquisition of mineral property assets in North America. The company’s flagship properties are located in the Red Lake Mining District of Ontario, Canada, renowned for over 30 million ounces of historic gold production. Other key projects extend into the neighboring Meen-Dempster Greenstone Belt of the Uchi Subprovince. The company’s management team is led by dedicated professionals, aiming to maximize shareholder value while employing modern exploration techniques and principles to achieve its goals.

The mission of StraightUp Resources is to maximize shareholder wealth through mineral discoveries at projects with robust potential, maintain long-lasting partnerships, and continue to focus on the acquisition, development and exploration of mineral resource properties in North America. The company’s objective is to continue to locate and develop economic, precious and base metal properties of merit.

The company’s 10,000-hectare (almost 25,000 acres) RLX Projects are contiguous to various Evolution Mining, Great Bear Resources, Pacton Gold and Dixie Gold properties. Its 2,000-hectare (just under 5,000 acres) Belanger Project is contiguous to Infinite Ore’s Fredart and Garnet/Arrow properties. StraightUp intends to conduct exploration on the RLX North, RLX South, Belanger and Ferdinand Gold properties located in the Red Lake District, a location touted as having one of the best metal-endowed greenstone belts in the world. The Bear Head Gold Project is located within the Meen-Dempster Greenstone Belt of the Uchi Subprovince, approximately 80 kilometers west of the Pickle Lake Gold Camp and 14 km northeast of the former gold mine, Golden Patricia. It amassed 620,000 ounces of gold at an average of 15.2 g/t Au from 1988-1997. The property is bordered by an Australian miner massive gold project. Known gold occurrences are already mapped on the Bear Head property, as are previous drill holes and results. Once the data is re-examined, an exploration budget and subsequent plans will be announced by the company.

Projects

Ontario’s Red Lake Mining District is one of Canada’s most prolific gold mining districts, renowned for its high-grade gold deposits. This is a mining-friendly, politically stable jurisdiction with a skilled labor force and infrastructure specifically built around meeting the needs of the mining industry.

RLX North & South Projects
At over 10,000 hectares, the RLX North and RLX South Projects represent a district-scale exploration opportunity. The RLX North and RLX South Projects are well positioned on-strike to the southeast of the district’s largest gold deposit (Red Lake Gold Mines – Evolution Mining). The project is adjacent to Great Bear Resources’ Sobel Project. Great Bear Resources is also in the process of evaluating the area for significant regional-scale structural controls and has proposed additional work on its neighboring project in the near term. These properties are highly accessible, with the southern boundary only eight kilometers from the paved highway into Red Lake, and can be accessed by forest service roads which traverse throughout the properties.

Belanger Project
Historic exploration work on the 2,000-hectare property has identified three significant surface exposures of gold, copper and silver. Early exploration work will focus on validating historic sampling results and following the occurrences along strike with a view to better understanding the nature and controls on mineralization. The property has excellent forest road access from the town of Ear Falls.

Ferdinand Gold Project
The Ferdinand property is situated within the southeastern extension of the Confederation-Uchi greenstone belt, one of the most metal-endowed greenstone belts in the world by square kilometer. It consists of 17 contiguous mining claims covering approximately 7,143 hectares (17,650 acres), located 13 kilometers northwest of the town of Slate Falls. Access is currently by logging roads, with forestry logging operations scheduled for expansion on the property. StraightUp recently completed a heliborne magnetic survey consisting of 1,994 line-km at 50m line spacings covering the entire property. The MAG survey was designed to provide geological and structural details of a 25km long southeast extension of the Confederation-Uchi greenstone belt along the Fry-Bamaji Deformation Zone.

Bear Head Gold Project
The Bear Head Gold Project comprises 31 mining claims totaling 1,944 hectares (4,800 acres) in the Meen-Dempster Greenstone Belt of the Uchi Subprovince, host to the Golden Patricia former gold mine, which produced 620,000 ounces of gold from 1988 to 1997. The Dorothy Main gold deposit owned by Ardiden lies only one kilometer from the Bear Head Gold Project. The Dorothy Main gold deposit holds noncompliant historical resources of 46,600 ounces of gold at 6.17 g/t Au. The company looks forward to adding the Bear Head Gold Project to its exploration efforts, with a work program to be conducted later in the fall of 2021.

Management Team

Mark Brezer is CEO, President, and Director of StraightUp Resources Inc. He is a successful businessman and holds a Geography/Geology degree from the University of Arizona. He has worked as a Project Manager and has overseen quality control, environmental monitoring and safety programs related to road construction. He has also held roles in media relations and marketing. He has been actively involved in the research and investment of junior mining companies for over 25 years. Time in the field and personal interest led him into extensive first aid training, and he is certified as a paramedic and firefighter.

Daniel Cruz is CFO and Director at StraightUp Resources. He is an experienced financial industry professional, having worked for 12 years as a senior investment advisor at Canadian broker-dealers, where he gained experience in equity research, asset management, investor relations, corporate finance and venture capital. He was one of the youngest Senior Investment Advisors at Canaccord Financial Inc. in 2010. He is also the co-founder and current director of Liquid Media Group Inc., a Nasdaq-listed issuer. During his tenure as CFO, he helped that company list on Nasdaq and raise over $20 million.

Matthew Coltura is a Director at StraightUp Resources. He has a Bachelor of Business Administration from Okanagan College, where he specialized in finance. He has worked in the finance industry for more than three years. Currently, Mr. Coltura is the CFO of Cayenne Capital Corp. He was also a director of PreveCeutical Medical Inc. from July 2016 to September 2019, a director of Sproutly Canada Inc. (formerly Stoneridge Exploration Corp.) from March 2015 to July 2018, and, since March 2018, has worked as a financial specialist at Quip Finance.

StraightUp Resources Inc. (CSE: ST), closed Tuesday’s trading session at $0.1571, even for the day. The average volume for the last 3 months is 11,674 and the stock's 52-week low/high is $0.1211/$0.27.

Recent News

Hero Technologies Inc. (OTC: HENC)

The QualityStocks Daily Newsletter would like to spotlight Hero Technologies Inc. (OTC: HENC).

Despite being one of the youngest sectors in the country, the United States’ state-legal cannabis industry has been dubbed the fastest growing industry in the country. Cannabis companies have generated billions of dollars in revenue in the few years cannabis has been legal, providing hundreds of thousands of job opportunities and filling state coffers with millions in cannabis tax revenue. Given the pace at which the industry is evolving, many cannabis companies, including Hero Technologies Inc. (OTC: HENC), are putting technology at the core of their operations in order to gain an edge over other sector actors.

Hero Technologies Inc. (OTC: HENC) is a cannabis company with a vertically integrated business model and plan that includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations and dispensaries that make the organization a multi-state operator (MSO).

The company was founded in 2004 and is headquartered in Dover, Delaware.

Portfolio

The company holds the majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation firm focused on providing optimal conditions to enhance photosynthesis and cultivation. Hero Technologies is planning expansion in cultivation and dispensary operations in Colorado through wholly owned subsidiary Mile High Green LLC, while expansion in Massachusetts is planned through another wholly owned subsidiary, MassCannabis LLC.

Hero Technologies also owns and operates HighlyRelaxing.com under Highly Relaxing LLC and recently acquired the assets of V Brokers LLC, now operating as Veteran Hemp Co. at VeteranHempCo.com.

BlackBox Systems and Technologies LLC

BlackBox Systems and Technologies LLC markets a proprietary cannabis aeroponic cultivation system designed for the large-scale production of top-shelf cannabis products. BlackBox offers the optimal conditions to enhance photosynthesis and promote the cultivation of large flowering plants. The system’s dry room, process room and secure storage were designed for precise control through each phase of the cannabis lifecycle. Weekly harvests are achieved using 13 separate BlackBox systems in independent modules.

The system provides a series of key benefits, including:

  • High-pressure nutrient delivery, with no nutrient or PH deficiencies
  • Sterile, 100% nutrient solution
  • Drain to Waste (no reuse of wastewater)
  • Low water usage (1 gallon per plant per day)
  • Constant PH and EC in reservoirs
  • Modular design (1 to 100 pods in any configuration)
  • Innovative proprietary engineering
  • Minimal cleanup
  • Media-less growing, suspended in the air, with no media waste
  • No pesticides

Highly Relaxing LLC

Highly Relaxing LLC is an emerging Henderson, Nevada-based operation dedicated to providing customers with honestly labeled, high-quality hemp-derived CBD products. Its current offerings include a topical CBD cream that provides localized relief from potential discomfort.

Veteran Hemp Co.

Veteran Hemp Co.’s mission is to provide a quality, consistent and delicious product for Americans looking to enjoy the hemp smoking experience. Its product is brought in by only the finest farming operations delivering the best genetics. Veteran Hemp Co. has its own custom harvest plans, drying facilities and all of the logistics that fall between. Veteran Hemp Co. prides itself on being a veteran-approved company.

Market Outlook

The global legal cannabis market is anticipated to reach $84 billion by 2028, expanding at a CAGR of 14.3% from 2021 to 2028. The driving factor for this forecast expansion is the increasingly widespread legalization of cannabis for medical and recreational use. Recreational use accounted for 60.3% of industry revenue in 2020.

North America provided the largest revenue share in the cannabis market, accounting for 91.1% of the global market in 2020. Due to the early legalization of medical and recreational cannabis in the region, the customer pool has increased exponentially (https://nnw.fm/snpHh).

The global CBD market was valued at $2.8 billion in 2020 and is expected to grow at a CAGR of 21.2% and reach $13.4 billion by 2028. North America is considered the most progressive region for cannabis and its derived products, with the highest number of CBD companies being based on the continent. The B2B (business to business) segment dominates the CBD industry, accounting for the largest revenue share at 59.6% in 2020 (https://nnw.fm/cGxXQ).

With its vertically integrated business model and development into a multi-state operator across multiple sectors of the cannabis industry, Hero Technologies is uniquely positioned to capitalize on the fast-growing market and the growing number of opportunities emerging as a result of legalization and increased popularity among consumers.

Management Team

Gina Serkasevich, CPA, CMA, is the Chief Executive Officer, Treasurer and Secretary of the Hero Technologies. She previously worked for Holloman Corporation as its Director of Finance beginning in June 2012 and was appointed Chief Financial Officer of Holloman Energy Corporation in August 2014. She has more than 30 years of domestic and international corporate accounting and finance experience. She served as U.S. Controller for EFLO Energy Inc., a company focused on the acquisition, exploration and development of oil and gas assets in North America. Prior to 2012, Ms. Serkasevich worked in the oil and gas tanker transportation industry as a Regional Financial Manager for AET Inc. Limited (2011-2012), as a Financial Consultant for OSG Ship Management Inc. (2009-2011) and as a Financial Controller/CFO for Stena Bulk LLC (1998-2008). During her 11-year tenure at Stena Bulk LLC, she established the financial, accounting and reporting requirements for its new joint ventures and tanker pools with Sonanagol USA and held the Company Secretary position on both of those companies’ boards of directors.

Dan McCarthy is the company’s Corporate Development Manager. He has spent more than 12 years in the institutional investment community, holding various investment banking and private equity executive roles. Thus far, he has been a part of over $1 billion in transactional value ranging from debt and equity to acquisitions and diversities throughout his career. Mr. McCarthy’s most recent role was Managing Director at Petro Capital, a Dallas-based private equity and investment bank. He began his career working for a private international consulting firm based in Washington, D.C., helping corporations and funds expand into non-G7 countries utilizing World Bank financing. He is also a graduate of the University of Kansas School of Business and completed the Mergers and Acquisitions program at the New York Institute of Finance.

James Rowland is Hero Technologies’ Marketing Advisor and an expert in marketing and e-commerce. He has held many high-level marketing and business-related roles. He is the Founder and current CEO of PerfectCheckout.com and the current Business Development Specialist at Fulfillment.com. Mr. Rowland has held multiple high-level positions throughout his career, which have provided him with the experience needed to bring success-backed marketing leadership skills to his current role with the company.

Hero Technologies Inc. (HENC), closed Tuesday’s trading session at $0.0722, up 1.3333%, on 30,102 volume. The average volume for the last 3 months is 30,102 and the stock's 52-week low/high is $0.024/$0.3174.

Recent News

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF)

The QualityStocks Daily Newsletter would like to spotlight Avricore Health Inc. (OTCQB: AVCRF).

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, has launched its HealthTab(TM) platform in various Shoppers Drug Mart(R) pharmacies located throughout British Columbia. This move marks the first time the company’s diabetes screening program has been available in Western Canada. Avricore signed a master agreement with Shoppers Drug Mart Inc. earlier this year. That agreement involved a pilot program that provided patients with access to point-of-care blood screening and health-data management for potential risks for developing diabetes and cardiovascular conditions. To view the full press release, visit https://ibn.fm/0m00l

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering, HealthTab™ (a wholly owned subsidiary), the company aims to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies.

HealthTab

HealthTab is a turnkey point-of-care testing solution that effectively turns pharmacies into diagnostic hubs (sometimes known as ‘Community Diagnostic Centers’, or CDCs) and connects them on a single, cloud-based platform.

The HealthTab network model is unlike anything in pharmacy today. It gives knowledgeable and trusted pharmacists a greater role in primary care delivery and empowers patients to take more control of their health. It also reduces costs and waiting times while providing many potential revenue streams, including equipment leasing & consumables, direct access testing, disease prevention & management programs, sponsored health programs, decentralized clinical trials, real world data (RWD) sets and third-party app integration through API.

Agreement with Shoppers Drug Mart

In June 2021, Avricore signed a Master Agreement with select Shoppers Drug Mart pharmacies to pilot the HealthTab platform. This agreement gives patients access to point-of-care blood screening and health-data management for potential risks relating to diabetes and cardiovascular conditions using HealthTab-integrated Afinion 2™ analyzers provided by Abbott Rapid Diagnostics.

Avricore is the first pharmacy solutions provider to partner with Abbott (NYSE: ABT), the global health care company and diagnostics leader in Canada. In May 2021, the company signed a supplier distribution agreement to expand the distribution of Abbott’s Afinion 2 and associated tests for diabetes and heart disease screening in community pharmacies in Canada. This agreement includes valuable HbA1c testing, a critical marker for the screening and management of diabetes.

Near Term Goals

Near term goals for Avricore include expansion into more pharmacies across Canada, followed soon after by entering the U.S. and UK markets. The company has made significant strides in testing and developing its technology and is moving into the commercialization stage.

Strategic partnerships like those with Abbott and select Shoppers Drug Mart pharmacies advance Avricore closer to becoming an incredibly dominant player in the community diagnostics space. The company aims to make actionable health information more accessible for everyone by creating the world’s largest rapid testing network in pharmacies.

Market Outlook

In 2020, the global point-of-care testing (POCT) market was valued at $34.49 billion and expected to expand at a compound annual growth rate (CAGR) of 9.4 percent to reach a projected $81.37 billion by 2028. This upsurge is expected to be driven largely by increased demand for screening and management tools for chronic diseases, as well as rapidly assessing infectious diseases such as COVID-19.

The accessibility of POCT has been an increasing priority of the world’s leading health organizations and experts. Pharmacies are ideal ‘hubs’ within the community to offer patients better access to the numbers they need to know for preventing or treating conditions such as diabetes and heart disease or the timely diagnosis of infection.

Management Team

Avricore’s leadership team brings a diverse portfolio of expertise across the health care and biotech industries, as well as technology, finance and communications. Together, they share a common vision of moving pharmacy forward and have positioned the company for significant future growth and expansion.

Hector Bremner is the CEO of Avricore. He has over 15 years of senior and executive experience across various industries, including international trade, natural gas, marketing and communications. He owned and operated TOUCH Marketing, a boutique marketing and communications firm based in Vancouver, from 2007 to 2013. Mr. Bremner has also served as the executive assistant to the Deputy Premier and Minister of Natural Gas Development, Responsible for Housing, as well as the Minister of International Trade and Minister of Small Business. In 2015, he joined Vancouver’s Pace Group Communications as VP of Public Affairs.

David Hall is the Chairman and a Director of Avricore. His leadership spans five different companies. He is currently the Chairman of RepliCel Life Sciences and a member of the boards of TrichoScience Innovations, AdvantageBC and Providence Health Care Research Institute. Mr. Hall also served as Chairman of Perceptronix Medical Inc.; Chief Financial Officer, Secretary & Treasurer of Angiotech Pharmaceuticals Inc.; President & Director at Newcastle Resources Ltd.; and Chairman for LifeSciences British Columbia.

Kiki Smith is Avricore’s CFO. She has over 20 years of experience assisting private and public companies in the roles of accountant, corporate controller and CFO in mining, oil & gas, real estate, high technology, food production and investment fund management. She currently provides consulting services in M&A, financial reporting and regulatory compliance to several public and private companies across several investment sectors. Ms. Smith is a member of the Chartered Professional Accountants of British Columbia and has a bachelor’s degree in economics from the University of British Columbia.

Rodger Seccombe is the Head of Avricore’s HealthTab division and the co-founder and former CEO of HealthTab Inc. Mr. Seccombe has over 20 years of experience launching and running companies in software, health care technology and clean energy. He is a recognized industry expert in direct-to-consumer and point-of-care testing technology. In 2006, he joined the start-up team at Canadian Bioenergy Corporation and helped pioneer the development of the renewable fuel industry in Canada. Before HealthTab, he designed and developed cloud-based informatics systems currently in use by some of the world’s leading medical laboratories and instrument manufacturers.

Avricore Health Inc. (OTCQB: AVCRF), closed Tuesday’s trading session at $0.13, even for the day. The average volume for the last 3 months is 20,000 and the stock's 52-week low/high is $0.06/$0.48562.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

  • Lexaria’s THC absorption animal study yielded promising results on the patented DehydraTECH(TM) technology
  • It showed that the technology required a shorter time to deliver the same THC levels than concentration-matched controls
  • Lexaria believes that through DehydraTECH, it is meeting the needs of medical THC users with its rapid delivery, increased overall THC delivery and high brain tissue delivery

Lexaria Bioscience's (NASDAQ: LEXX) just-concluded oral tetrahydrocannabinol (“THC”) absorption animal study, THC-A21-1, yielded promising results on the effectiveness of the company’s patented DehydraTECH(TM) drug delivery technology.

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules.  DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Tuesday’s trading session at $6.35, off by 1.5504%, on 48,813 volume. The average volume for the last 3 months is 47,714 and the stock's 52-week low/high is $3.9751/$12.50.

Recent News

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, hosted the 2021 LD Micro Main Event, both in-person in Los Angeles and virtually via its Sequire Virtual Events platform. The event marked the first in-person conference for LD Micro in almost two years and brought physical and virtual elements together to form a truly unique experience. Replays from the 139 presenting companies will continue to be available for viewing for three months. Interested parties should visit the event website to access and view the presentations. To view the full press release, visit https://ibn.fm/IGKpI

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Tuesday’s trading session at $5.49, off by 5.9932%, on 149,824 volume. The average volume for the last 3 months is 149,824 and the stock's 52-week low/high is $2.27/$7.29.

Recent News

Tingo Inc. (OTCQB: IWBB)

The QualityStocks Daily Newsletter would like to spotlight Tingo Inc. (IWBB).

Tingo (OTCQB: IWBB), an agri-fintech company focused on foundation-level services in Africa, has sought to build a digitally inclusive ecosystem that promotes financial inclusion and delivers disruptive micro-finance solutions, empowers societies and produces social upliftment in rural communities. In Nigeria, farming accounts for over 20% of the country’s economy, yet most of the nation’s farmers live well below the poverty line due to the mechanics of the regional agricultural economy. A recent article reads, “Tingo has centered their business model around four core business pillars, namely — mobile phone leasing, mobile voice and data services, the Nwassa Marketplace Platform, and Tingo Pay. In effect, the vertically integrated business model enables Nigeria and the wider African continent’s farmers to procure a Tingo-manufactured handset using Tingo’s mobile data and voice services. Farmers can then access the Nwassa Platform, Tingo’s proprietary agritech marketplace that provides the continent’s farmers with access to domestic and global markets to secure more competitive pricing for their crops… Tingo has aimed to provide an opportunity for Africa to be a core focal point to solve several key areas of concern, including food security, gender equality, financial inclusion and poverty alleviation, to name but a few.” To view the full article, visit https://ccw.fm/TswtR

Tingo Inc. (OTCQB: IWBB) is a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa. The company aims to be Africa’s leading agri-fintech player, transforming rural farming communities to connect through its proprietary platform to meet their complete needs – from inputs and agronomy to off take and marketplace – and deliver sustainable income in an impactful way. The company’s vision is to build complete digitally inclusive ecosystems that promote financial inclusion and deliver disruptive micro-finance solutions, empower societies, produce social upliftment in rural communities and open international opportunities.

Tingo believes that a truly connected world will help contribute to a better global society. The company’s core focus areas are telecoms, financial services/fintech and agritech. Tingo’s goal is to provide a best-in-class customer experience, support the domestic economies of its host countries and support technological and financial inclusion to end the poverty premium. Through this, Tingo hopes to deliver attractive returns to shareholders while investing in the long-term future of the company and its subsidiaries.

Global climate change is challenging sustainable production and food security. Tingo’s strategy and market execution provide an opportunity for Africa to be a core focal point to solve a number of key areas of concern, including food security, gender equality, financial inclusion and poverty alleviation, to name a few. Disruption of micro finance through the use of DeFi-based stable coins and smart contracts will give agri-communities access to capital markets-driven digital finance solutions that make them more competitive and sustainable economically, striking a good balance of returns between digital asset providers and Tingo as the service partner. This innovation will deliver significant access to much needed finance at ‘Grassroot’ levels, delivering tangible social upliftment and GDP growth in the African markets served by Tingo.

Tingo Mobile, with more than nine million subscribers, is Nigeria’s leading technology and device-as-a-service platform aimed at accelerating digital commerce, especially in the country’s agritech and fintech verticals. The company helps farmers acquire mobile phones through a unique leasing plan, connecting them to mobile and data networks through its own virtual mobile network. Tingo also connects farmers to markets, services and resources via Nwassa, its digital agritech marketplace platform that commenced operations in 2020. The company has also launched a beta version of TingoPay – a B2B and B2C fintech app aimed at providing financial services to users inside and outside of the agriculture value chain. Among the services offered are mobile wallets, payment processing and access to specialist lenders, insurers and pension products.

Tingo will soon announce its innovative blockchain-based solution for use of digital stable coins to empower frictionless trade across borders in Africa. The company’s market-proven model in Nigeria is its core foundation, enabling Tingo to deliver the same service model across Africa to become the continent’s leading agri-fintech business powered through smartphone technology.

The African Continental Free Trade (ACFT) plan will be a key framework to prepare the company to be the leading intra-Africa trading hub for trade flows across Africa in the medium term, when it is likely the agreement will be executed into tangible activity. Tingo is well positioned to easily transform the goals of the ACFT into reality when finally implemented by the African Union and the various African countries that have not signed up.

Tingo posted total revenue of $594 million in 2020, with $212 million EBITDA. As of December 31, 2020, Tingo has 9,344,000 subscribers. The company is confident that these figures will grow through its expansion across Africa and natural progression of business in Nigeria.

Businesses

Tingo has four core businesses:

  • Mobile Phone Leasing – Tingo has distributed almost 30 million mobile handsets since 2014 and will continue to replace the devices of its installed customer base every three years. Tingo Mobile provides the latest mobile phone handsets at an affordable price point and allows customers to spread payments over 36 months.
  • Mobile Voice and Data Service – Through a mobile virtual network, Tingo provides its customers with voice and data services, allowing customers to communicate effectively, both inside and outside the agricultural ecosystem.
  • Nwassa Marketplace Platform – Nwassa is Tingo’s proprietary agritech platform which provides Africa’s farmers with access to global markets to secure more competitive pricing for their crops. The platform processes 500,000 daily transactions with a value of over $8 million. A select group of trusted partners can assist smallholder farmers and agricultural cooperatives with packaging, warehousing, and dry and wet cargo logistics, as well as up-to-date information from the global agricultural sector. Tingo provides its customers with digital wallet services, which enable them to send and receive domestic payments, monitor cash flow in real time and securely hold money. The company also provides access to other services, such as utility bill payment, virtual airtime top-up, insurance services and alternative lending solutions.
  • TingoPay – Since the launch of the Nwassa platform, Tingo has been a dominant player in the B2B fintech vertical. After many successful months of operating Nwassa, Tingo entered the fintech B2C vertical to extend its B2B offering to a broader market beyond agriculture.

TingoPay is still in its beta phase and will launch in 2021 with a comprehensive marketing campaign. TingoPay offers the following services:

  • Tingo Wallet top-up
  • Peer to Peer payments, inclusive of merchant payments at the stores
  • Utility payments – airtime, broadband, cable, electricity, water, hotel, flights etc.
  • Pension payments
  • QR code payment services

Market Opportunity

Africa is the second-largest continent by population. It is also the youngest by far, with a median age of 18 for its 1.3 billion people. Tingo believes the building blocks for growth in Africa’s agriculture industry are in place and that the company is well positioned to participate in the upside. Sub-Saharan Africa’s population is growing at a rate of 2.7 percent per year. At the current growth rate, the continent’s population will double by 2050. Africa’s youthfulness represents a significant opportunity for material growth in demand for agricultural commodities. This younger generation is also being born into a digital world and is comfortable using technology.

Africa’s governments are improving business conditions for entrepreneurs and small businesses. Sub-Saharan Africa’s World Bank Doing Business rank has improved from 45 in 2004 to 65 in 2020. Tingo believes this trend will continue and encourage establishment of more new ventures across all economic sectors, including agriculture.

Africa attracted $407 billion of Foreign Direct Investments (“FDI”) between 2014 and 2018. Investments are increasingly focused on services and industrial sectors. Only 20 percent of investments are in extractive industries – a clear reversal from 2008, when 55 percent of FDI was aimed at resource extraction. Tingo believes FDI into Africa will help resolve significant infrastructure constraints and create value for agribusiness.

Management Team

Dozy Mmobuosi is the CEO of Tingo. He cofounded Tingo Mobile PLC (Nigeria) in 2001 and led the design and launch of Nigeria’s first SMS banking solution, which is still in use in the country today. He also headed a team of more than 120 Chinese and Nigerian engineers in the construction of two mobile phone assembly plants in Nigeria, which have produced and distributed 20 million phones across the country. He has led Tingo’s growth to more than $600 million in revenue annually. He holds a Ph.D. in Rural Advancement from UPM Malaysia.

Dakshesh Patel is the CFO of Tingo. He was formerly CFO of NatWest’s Global Debt and Investment Banking division. He has served as a Director at Gerken Capital Associates, a San Francisco-based alternative asset fund manager. He also led the restructure of Lloyds Banking Group (last financial crisis); managed integration of two leading shipping groups’ global treasury function to create world-leading shipping group Maersk Shipping; built three fintech companies; and exited one to Worldpay. Mr. Patel has strong banking experience, with a focus on Africa. He is a chartered accountant.

Chris Cleverly is president of Tingo. He has served as CEO of the Made in Africa Foundation, and as CEO of blockchain payments gateway startup Kamari. He has been a board member of several companies, both public and private, in the UK, India, China and Africa. He has advised multiple UK companies on their entrance into African markets, and regularly advises the UK Government on development issues and African governments on investment issues.

Clarence Simms is the Chief Technology Officer at Tingo. He has 25 years of IT and IT management experience. He has worked in IT Shared Services Technical Operations and IT Program Management for Huawei Technologies and MTN. As an entrepreneur, he created Africaprepay.com, a service that allows African Diaspora travelers to send airtime, pay bills, send mobile money and transfer money to a bank account from anyplace in the world.

Rory Bowen is the Chief of Staff at Tingo. Mr. Bowen started his career in traditional capital and derivatives markets working for Moneycorp and Tradition UK in European and emerging markets across FX, interest rate derivative and government bond markets. He has also spent time with one of Europe’s fastest growing fintech’s banking circles. Before joining Tingo, he was Chief of Staff at FinTech Alliance, an organization established in partnership with the UK Government Department for International Trade to foster innovation, growth and foreign direct investment (FDI) in the financial services sector and facilitate greater public/private cooperation.

Tingo Inc. (OTCQB: IWBB), closed Tuesday’s trading session at $2.37, off by 5.9524%, on 450 volume. The average volume for the last 3 months is 450 and the stock's 52-week low/high is $1.01/$8.98.

Recent News

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF)

The QualityStocks Daily Newsletter would like to spotlight Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF).

  • Playgon Games is a SaaS technology company focused on licensing its online gaming technology to gaming operators around the world
  • The company has recently revealed that it saw player betting turnover rise to $24.2 million as of the first half of October, a 1500% increase relative to September’s $1.6 million
  • The pandemic has hastened a switch away from physical casinos and towards online gaming; the online gaming market is now expected to grow to an annual value of $127.3 billion by 2027
  • Playgon Games’ business model effectively allows investors to capitalize on overall gaming sector growth while simultaneously forgoing the sector’s elevated player acquisition costs

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF), a propriety SaaS technology company delivering mobile live dealer technology to online gaming operators globally, has recently revealed that it has surpassed $24.2 million in player betting turnover in the first half of October 2021, up from a mere $1.6 million for the entire month of September (https://ibn.fm/tFsRa). The company’s multi-tenant gateway provides online operators the ability to offer iGaming software solutions to their customers. “Playgon’s proprietary technology provides digital games for online gambling sites and mobile device apps, with the company licensing its mobile live-dealer technology to online gaming operators worldwide. Playgon combines high-definition live streaming dealers with state-of-the-art augmented reality betting to provide the most authentic casino experience, live from Las Vegas. Playgon’s mobile platform features popular table games, all optimized for one-handed play on mobile devices,” reads a recent article discussing the company. “The COVID-19 pandemic has accelerated an already existing shift away from location-based casinos to online gambling. At the same time, the proliferation of mobile devices has provided players with new access to betting. A younger, tech-savvy consumer demographic is driving adoption of digital gaming globally. To meet this demand, Playgon has launched a studio with 10 gaming tables from which its live dealer streaming video originates. The company’s platform is live with multiple online casino operators through four aggregator clients in South Africa and Europe, and commitments are coming in from more.” To view the full article, visit https://ibn.fm/M00IH

Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) is a SaaS technology company focused on developing and licensing digital content for the growing global iGaming market. The company provides a multi-tenant gateway that allows online operators the ability to offer their customers innovative iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table Games and Daily Fantasy Sports. Seamless integration at the operator level allows customer access without requiring the sharing of any sensitive customer data. Playgon games run on any browser and any device as fast and secure as a native app, without requiring any app store download. All that’s needed is a stable internet connection. The gaming experience is identical across all mobile devices. As a true business-to-business digital content provider, the company’s products are scalable turnkey solutions for online casinos, sportsbook operators, location-based operators, media groups, and big database companies.

Playgon’s proprietary technology provides digital games for online gambling sites and mobile device apps, with the company licensing its mobile live-dealer technology to online gaming operators worldwide. Playgon combines high definition live streaming dealers with state-of-the-art augmented reality betting to provide the most authentic casino experience, live from Las Vegas. Playgon’s mobile platform features popular table games, all optimized for one-handed play on mobile devices.

The COVID-19 pandemic has accelerated an already existing shift away from location-based casinos to online gambling. At the same time, the proliferation of mobile devices has provided players with new access to betting. A younger, tech-savvy consumer demographic is driving adoption of digital gaming globally. To meet this demand, Playgon has launched a studio with 10 gaming tables from which its live dealer streaming video originates. The company’s platform is live with multiple online casino operators through four aggregator clients in South Africa and Europe, and commitments are coming in from more.

Playgon plans to expand the studio to 25 tables in the near term and is working to establish a U.S. strategy. The company will continue to expand licensing of its live dealer games to iGaming operators worldwide under a SaaS license agreement. As a B2B software supplier, Playgon avoids player acquisition costs.

Games

Live Dealer Casino

Playgon offers the first and only Live Dealer Casino streaming live from Las Vegas. The company brings cutting-edge handheld features and functionality to the mobile generation of gaming enthusiasts who demand a world-class gaming experience on all devices. Playgon’s Blackjack delivers the look and feel of location-based casino tables with features providing players with the most unique user experience. The company’s true-to-life Roulette offers players a clear and uninterrupted view of the dealer, wheel, ball, bets, results, trends and statistics. Players can strategize, place multiple bets, track results and review trends without ever losing focus of the game.

Playgon’s traditional Baccarat and proprietary Tiger Bonus Baccarat™ prove their worth by not only recognizing the need for a prominent product, but by adding elements which separate them from the pack without removing their authenticity. The games mix advances in technology with the traditional game attributes that have resonated and captivated players for hundreds of years.

eTable Games

To lead the rise of mobile-first gaming, Playgon developed a user experience perfected for one-handed play. Providing this next evolution in gaming technology ensures the company’s client operators loyalty from existing customers and is a powerful strategy to attract and retain new players. Playgon’s VEGAS LOUNGE™ brings together an innovative mix of games, technology and gameplay that offers players an authentic experience and real Las Vegas casino fun every time, everywhere.

Daily Fantasy Sports

Playgon’s Daily Fantasy Sports (DFS) are a subset of fantasy sport games which typically target a younger demographic. DFS provides iGaming operators a turnkey fantasy sports platform that can quickly go to market, integrate with the operator’s existing operations and services, and be customized to match and enhance the operator’s brand. The platform is mobile and desktop friendly, built for regulated market environments, and allows operators to monetize users through a network of shared liquidity.

Market Outlook

Online casinos and sports betting sites/apps are increasingly adding market share to traditional location-based casinos. This trend is only expected to accelerate as millennials reach their peak earning years and Gen Z youth begin to complete their education and move into careers. These generations are completely comfortable with online recreation, as well as tech like digital wallets and digital gameplay that underpins Playgon Games. The company has been described as “Netflix + Vegas, all in one.”

The online gambling market is slated to reach a value of $127.3 billion by 2027, according to Grand View Research, with much of the growth expected from the U.S. and Asia. Even Europe, the most mature gaming market, is expected to grow at a rate of 20-25 percent year over year. The current global online Live Casino TAM is estimated at about $6 billion annually, and revenue is forecast to reach more than $8 billion by 2023 and more than $13 billion by 2027.

Management Team

Darcy Krogh is CEO of Playgon Games. He is a veteran of the iGaming industry with over 20 years of experience. In 1999, he co-founded Chartwell Technology Inc., which pioneered the development of browser-based digital content for the iGaming industry. After that company was sold to Amaya Gaming Group, he served as VP Business Development with Amaya. In 2016, he started Playgon Games (formally Global Daily Fantasy Sports Inc.) as President and CEO. His experience in the online gaming industry includes sales and marketing, relationship management, corporate finance, M&A, and strategic corporate development.

Guido Ganschow is President of Playgon Interactive. He has more than 12 years of experience in creating real-time Live Dealer technology and platforms and was the co-founder and Creative Director for a Macau-based casino consortium. Between 2008 and 2014, he successfully created and established Live Dealer platform businesses in Asia and Europe, and executed commercial partnerships, sales, and integration of the Live Dealer solution with major global gaming brands, including Ho Gaming Group, Chartwell Technology and Amaya Gaming Group.

Steve Baker is COO of Playgon. He is a former VP Operations for Shaw Communications, where he was directly involved in video streaming, home entertainment, new products, sales and M&A. He oversaw revenue growth from $300 million to $2.8 billion and employee growth from 350 to 13,000. He has broad experience and a proven record in development and implementation of cost effective and efficient growth strategies transitioning businesses from development to operations.

Harry Nijjar is CFO of Playgon Games. He is currently a Managing Director with Malaspina Consultants Inc. and provides CFO and strategic financial advisory services to his clients across many industries. This experience has allowed him to help his clients successfully navigate the regulatory and financial environments within which they operate. Mr. Nijjar holds a CPA-CMA designation from the Chartered Professional Accountants of British Columbia.

Playgon Games Inc. (PLGNF), closed Tuesday’s trading session at $0.2256, off by 5.4088%, on 21,525 volume. The average volume for the last 3 months is 21,525 and the stock's 52-week low/high is $0.197/$1.32.

Recent News

Perpetual Industries Inc. (OTC: PRPI)

The QualityStocks Daily Newsletter would like to spotlight Perpetual Industries Inc. (PRPI).

Perpetual Industries Inc. (OTC: PRPI) is an incubator for the development of innovative, energy-efficient technologies aimed at commercializing products that have the potential to impact and advance a wide range of industries on a global scale.

The company’s team of experts and trusted industry partners have the resources to provide essential components needed to take projects from their initial stages through to the end products. Perpetual Industries values strict controls and high levels of quality through all stages of research, development, manufacturing and commercialization.

Perpetual Industries was founded by President, Chairman and CEO Brent W. Bedford in 2005. It is located in Auburn, Indiana.

R&D Portfolio Overview

Perpetual Industries is expanding expertise and knowledge of energy-efficient technology by developing low-cost, green energy solutions for various industries, including artificial intelligence, blockchain mining, graphic rendering, renewable energy, cloud computing and internet of things (IoT), all while continuing research, development and commercialization of its proprietary XYO Balancing Technology in key applications.

XYO Balancing Technology

XYO Balancing Technology delivers high-performance solutions for inefficiencies that commonly affect rotating equipment, machinery and devices. It is designed to harness rotor displacement energy to move compensating masses and automatically correct for imbalances, effectively reducing vibration.

Key highlights of the company’s XYO Balancing Technology include:

  • Customized XYO balancers can be created for almost everything that rotates, providing virtually unlimited potential applications.
  • XYO Balancing Technology is optimized specifically to eliminate vibration in rotating equipment and enable environmentally responsible products to operate more efficiently.
  • Leveraging a proprietary design, XYO Balancing Technology is the result of over 25 years of research and development effort.

WindSilo – Vertical Axis Wind Turbine

Implementing its proprietary XYO Balancing Technology, Perpetual Industries’ WindSilo turbine improves balancing issues that are common in most wind turbines today. The company’s design is engineered to allow for much faster spin speeds and greater energy output.

The company believes that this innovative turbine design could eliminate the expensive traditional methods of balancing wind turbines while increasing their performance, reliability and efficiency.

In November 2020, Perpetual Industries announced that Trine University, a private post-secondary institution located in Angola, Indiana, had been awarded a grant to assist the company in the development of the WindSilo.

The XYO Washing Machine

Perpetual Industries is currently developing a proprietary domestic washing machine design implementing XYO Mechanical Balancers to dynamically compensate for variable mass imbalance during the spin cycle. The company expects these efforts to produce a number of benefits, including higher spin speeds, reduced energy consumption, decreased noise emissions and less mechanical wear & tear.

The company’s research shows tremendous market potential for a more efficient washing machine design. With an estimated 70 million washing machines produced annually and over 500 million used daily, even a small reduction in energy consumption could be pivotal. Reducing energy usage of all washing machines by just 15% would save enough energy to power the city of Milan. Perpetual Industries’ energy efficient design is expected to reduce energy usage by up to 50%.

Prototype testing of Perpetual Industries’ design has established the XYO Washing Machine as highly effective at reducing vibration when built into the spin basket assembly.

Green Energy Mining System

Using its expertise and knowledge of environmentally friendly technologies, Perpetual Industries is developing low cost, environmentally responsible energy solutions for powering large scale blockchain mining operations.

The company’s Green Energy Mining (GEM) System is being hailed as the next generation of energy efficient cryptocurrency mining. Powered by renewable & surplus energy sources such as wind, solar, natural gas, wind and geothermal that utilize battery storage technology, the platform addresses rising demand for computing power.

Renewable Energy Market Outlook

The global renewable energy market was valued at $928 billion in 2017 and is expected to continue expanding at a CAGR of 6.1%, resulting in a value of $1.5 trillion by 2025, according to Allied Market Research (https://ibn.fm/C06xF). Hydroelectric power is projected to be the most lucrative segment of the entire global renewable energy industry, followed by the wind, bioenergy, solar and geothermal segments.

Worldwide Auctioneers Acquisition

In January 2021, Perpetual Industries announced its acquisition of The Worldwide Group LLC, operating as Worldwide Auctioneers.

Worldwide Auctioneers is a U.S.-based boutique auction firm specializing in the sale and acquisition of classic vintage motorcars at auction around the globe. With an impressive 20-year history and a talented team, Worldwide offers an extensive range of personalized services to collectors, including private sales, appraisal, collection direction and consultancy, estate planning and asset management.

Perpetual Industries expects Worldwide to benefit from multiple channels of collaboration moving forward, particularly within the company’s blockchain division.

Classic Car Market Outlook

The U.S. classic car market has recorded steady expansion over recent years, accounting for revenue of approximately $12.63 billion in 2020, according to Statista (https://ibn.fm/Fydhj). The same report forecasts growth to $15.52 billion by 2023, representing a CAGR in excess of 7 percent. Classic car dealers in the U.S. have cornered a significant portion of this market opportunity. According to data from IBISWorld (https://ibn.fm/k30F5), the market for classic car dealers in the U.S. was valued at $2.1 billion in 2021, achieving a CAGR of 1.5% from 2016 to 2021, despite the challenges associated with the COVID-19 pandemic.

Management Team

Brent W. Bedford is the President, Chairman, CEO and founder of Perpetual Industries. He has held these roles continuously since founding the company in January 2005. He has a deep understanding of every aspect of the company’s business, products and markets. He also has experience developing corporate strategies, assessing emerging industry trends and carrying out business operations. Mr. Bedford has a strong background in mechanical applications, with expertise in finance, private startups, public startups and corporate turnarounds.

Carl Dilley is Director and COO of the company. He is a career entrepreneur who has served as a C-level officer in many different companies across multiple industries. Mr. Dilley has been instrumental in taking over 400 companies public. He has been involved in the investment industry since 1983. He has held FINRA series 24, 66 and 7 Securities licenses, allowing him to perform retail, investment, banking and new listing services functions.

William Griffin Thomas, CPA, is the company’s CFO. He holds a Bachelor of Science in Accounting from the University of Tampa and a Bachelor of Science in Agribusiness from the University of Florida. Mr. Thomas is a licensed CPA with over 19 years of experience spanning both the private and public sectors, as well as time with non-profits. His expertise includes auditing, budget analysis, fixed assets, financial modeling, SEC financial reporting, GAAP compliance and fair value measurements.

Perpetual Industries Inc. (PRPI), closed Tuesday’s trading session at $0.29, up 20.8333%, on 1,035 volume. The average volume for the last 3 months is 1,035 and the stock's 52-week low/high is $0.08/$0.925.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Wednesday's trading